Pro-Lab Diagnostics

Pro-Lab Diagnostics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Pro-Lab Diagnostics is a long-established, private company operating in the clinical diagnostics sector, specializing in microbiology and immunodiagnostics. The company has a commercial-stage portfolio centered on practical laboratory tools, including its flagship Microbank™ organism storage system, Prolex™ latex kits, and the original TransVelope™ specimen transport bag. It serves a stable but competitive niche market of hospital and investigative labs, emphasizing quality, cost-effectiveness, and regulatory compliance. The company appears to be a steady, revenue-generating entity with a direct-to-customer e-commerce model, though it operates at a smaller scale compared to global diagnostics giants.

Infectious DiseaseGeneral Microbiology

Technology Platform

Expertise in manufacturing latex agglutination immunoassays, organism storage/retrieval systems (Microbank™), and specimen transport solutions, underpinned by ISO 13485:2016 quality management systems.

Opportunities

The stable demand for routine microbiology supplies and cost-effective diagnostics in clinical and veterinary labs presents a consistent market.
ISO 13485:2016 certification facilitates international sales growth in regulated markets.
The growing veterinary diagnostics sector offers a potential expansion avenue for its existing product lines.

Risk Factors

Core technologies face long-term risk of displacement by automated and molecular diagnostic platforms.
Intense competition from large, diversified global diagnostics corporations and distributors could pressure margins and market share.
Reliance on traditional manufacturing and distribution exposes the company to supply chain and operational risks.

Competitive Landscape

Pro-Lab operates in a highly competitive segment dominated by large players like Thermo Fisher Scientific, BD, bioMérieux, and Sigma-Aldrich (MilliporeSigma). It differentiates through specialization in microbiology/immunodiagnostics, a focus on cost-effectiveness, and direct customer relationships, but competes against these giants' vast portfolios, R&D budgets, and global sales networks.